Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$106K Hold
490
0.06% 258
2022
Q1
$113K Sell
490
-42
-8% -$9.95K 0.03% 454
2021
Q4
$150K Buy
532
+530
+26,500% +$138K 0.04% 396
2021
Q3
$479 Hold
2
﹤0.01% 942
2021
Q2
$499 Hold
2
﹤0.01% 943
2021
Q1
$386 Hold
2
﹤0.01% 822
2020
Q4
$358 Sell
2
-30
-94% -$5.05K ﹤0.01% 763
2020
Q3
$5.04K Hold
32
﹤0.01% 506
2020
Q2
$4.54K Hold
32
﹤0.01% 457
2020
Q1
$3.45K Buy
32
+20
+167% +$2.86K ﹤0.01% 474
2019
Q4
$1.91K Hold
12
﹤0.01% 497
2019
Q3
$1.79K Hold
12
﹤0.01% 500
2019
Q2
$1.93K Sell
12
-7,430
-100% -$1.04M ﹤0.01% 512
2019
Q1
$1.07M Buy
7,442
+7,430
+61,917% +$990K 0.21% 106
2018
Q4
$1.39K Sell
12
-9,294
-100% -$1.13M ﹤0.01% 548
2018
Q3
$1.21M Buy
+9,306
New +$1.12M 0.23% 97

Other funds holding IQV

Exane Derivatives's IQV Position: Q2 2022 in Review

Exane Derivatives held its IQVIA (IQV) position steady in Q2 2022 at 490 shares worth $106K. The position accounts for 0.06% of the portfolio, ranked #258.

Exane Derivatives first reported a position in IQV in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.21M in Q3 2018. 885 funds tracked by Wall St. Rank hold IQV as of Q2 2022.

  • Exane Derivatives held 490 shares of IQVIA worth $106K as of Q2 2022.
  • Exane Derivatives left its IQVIA share count unchanged in Q2 2022.
  • IQVIA made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #258 holding.
  • Exane Derivatives first reported a position in IQVIA in Q3 2018 and has held it in 16 quarters since.
  • Exane Derivatives's IQVIA position peaked at $1.21M in Q3 2018.
  • 885 funds tracked by Wall St. Rank held IQVIA as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.